The Effects of St. John's Wort on Premenstrual Syndrome in Single Women: A Randomized Double-Blind, Placebo-Controlled Study

다국어 초록 (Multilingual Abstract)

Objective : St. John's wort (SJW) is known to be effective in treating depression and mood disorders. This study was designed to verify the effect of SJW for mood symptoms of premenstrual syndrome in single women.
Methods：A total of 30 single women who suffered from premenstrual symptoms were recruited for this study and followed up for three menstrual cycles. The study used double-blind randomized controlled clinical trials. Subjects were recruited from among healthy single women with no history of medication. We included women who scored above 10 on the Beck Depression Inventory (BDI) or above 217 on the Premenstrual Assessment Form (PAF). We excluded women with endocrine disease, genitourinary,obstetric or gynecologic disease, any previous psychiatric disease, or who were taking medication. The 30 subjects were divided randomly into two groups. The experimental group (n = 16) were treated with 600 mg/day of hypericin, an extract of SJW. The control group (n = 14) were given a placebo that looked similar to the SJW extract. From the first to the third menstrual cycle, all subjects wrote a daily diary to record any PMS symptoms. From the second to the third menstrual cycle,all subjects took two pills daily and continued to take the pills for about two months. We investigated BDI, PAF, and self-assessment of unpleasant feelings using a visual analogue scale (VAS) at baseline and again at the end of the third menstrual cycle.
Each variant was further analyzed via nonparametric testing, and changes in values from before to after the study were assessed using the Mann-Whitney U-test.
Results：Compared to the placebo group, the SJW group exhibited no significant differences in VAS, total PAF, or BDI. However,the groups differed significantly (p＜0.05) on three PAF subtype scores: emotional lability, hostility/anger, and impulsivity.
Conclusion：The results suggest that SJW affects emotional lability, hostility or anger, and impulsivity related to premenstrual syndrome in single women.

참고문헌 (Reference)

1 박영환, "일병원 간호사군에서 월경전 불쾌기분장애의 유병율과 직업적 기능의 저하" 대한신경정신의학회 40 (40): 832-841, 2001

2 Hicks SM, "The significance of “Nonsignificance” in randomized controlled stuidies: a discussion inspired by a double-blinded study on St. John’s worts (Hypericum perforatum L.) for premenstrual symptoms" 10 : 925-932, 2004

3 Ernst E, "The risk-benefit profile of commonly used herbal therapies: Ginkgo, St. John's wort, Ginseng, Echinacea, Saw Palmetto, and Kava" 136 : 42-53, 2002

4 Min AK, "The effects of educational program for women with premenstrual syndrome" 3 : 31-40, 1997

5 Ko SG, "The effects of cognitive-behavioral group therapy for premenstrual syndrome" 4 : 1-11, 2004

6 Halbreich U, "The diversity of premenstrual changes as reflected in the Premenstrual Assessment Form" 65 : 46-65, 1982

7 Lee JY, "The Analysis of the Premenstrual Symptoms in Different Age Groups" 25 : 510-522, 1986

8 Huang KL, "St. John's wort (Hypericum perforatum) as a treatment for premenstrual dysphoric disorder: case report" 33 : 295-297, 2003

9 Barnes J, "St. John's wort (Hypericum perforatum L.): a review of its chemistry, pharmacology and clinical properties" 53 : 583-600, 2001

10 Linde K, "St John's wort for depression: meta-analysis of randomised controlled trials" 186 : 99-107, 2005

11 Ernst E, "Second thoughts about safety of St John's wort" 354 : 2014-2016, 1999

12 Freeman EW, "Reliability and validity of a daily diary of premenstrual syndrome" 65 : 97-106, 1996

13 Beck AT, "Psychometric properties of the Beck Depression Inventory (BDI): twenty-five years of evaluation" 8 : 77-100, 1988

14 Fetrow CW, "Professional's handbook of complementary and alternative medicine. 2nd edition" Lippincott Williams & Wilkins 746-749, 2001

15 Steiner M, "Premenstrual syndrome and premenstrual dysphoric disorder: guidelines for management" 25 : 459-468, 2000

16 Koh Y, "Premenstrual Syndrome-Evaluated by premenstrual Assessment Form & Daily Rating Form-" 34 : 156-164, 1995

17 Kim T, "Medical treatment of premenstrual syndrome" 48 : 672-678, 2005

18 Butterweck V, "Mechanism of action of St John's wort in depression: what is known?" 17 : 539-562, 2003

19 Gü.zelcan Y, "Mania during the use of a combination preparation with St. John's wort (Hypericum perforatum)" 145 : 1943-1945, 2001

20 Linde K, "Large-scale observational studies of hypericum extracts in patients with depressive disorders-a systematic review" 12 : 148-157, 2005

21 Schrader E, "Equivalence of St. John's wort extract (Ze 117) and fluoxetine: a randomized, controlled study in mild- moderate depression" 15 : 61-68, 2000

22 Kasper S, "Efficacy of St. John's wort extract WS5570 in acute treatment of mild depression: a reanalysis of data from controlled clinical trials" 258 : 59-63, 2008

23 Leucrubier Y, "Efficacy of St. John's wort extract WS 5570 in major depression: a doubleblind, placebo-controlled trial" 159 : 1361-1366, 2002

24 Brenner R, "Comparison of an extract of hypericum (LI 160) and sertraline in the treatment of depression: a double-blind, randomized pilot study" 22 : 411-419, 2000

25 Williams JG, "Behavioral measurement of severe depression" 27 : 330-333, 1972

26 Williams JW Jr, "A systemic review of newer pharmacotherapies for depression in adults: evidence report summary" 132 : 743-756, 2000

27 Han SH, "A study on the menstrual pain and dysmenorrhea, factors influenced to them, and self-management method for them of college students" 5 : 359-375, 1999

28 Jun EM, "A study on menstrual symptoms, coping and relief of symptoms in female college students" 9 : 161-169, 2003

29 Rhee MK, "A standardization study of Beck Depression Inventory (II): Korean Version (K-BDI): Validity" 4 : 96-104, 1995

30 Fava M, "A double-blind, randomized trial of St John's wort, fluoxetine, and placebo in major depressive disorder" 25 : 441-447, 2005